0000950170-23-070743.txt : 20231215 0000950170-23-070743.hdr.sgml : 20231215 20231215161508 ACCESSION NUMBER: 0000950170-23-070743 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20231213 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing FILED AS OF DATE: 20231215 DATE AS OF CHANGE: 20231215 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kintara Therapeutics, Inc. CENTRAL INDEX KEY: 0001498382 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 990360497 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37823 FILM NUMBER: 231490483 BUSINESS ADDRESS: STREET 1: 9920 PACIFIC HEIGHTS BLVD, SUITE 150 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 350-4364 MAIL ADDRESS: STREET 1: 9920 PACIFIC HEIGHTS BLVD, SUITE 150 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: DelMar Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20130123 FORMER COMPANY: FORMER CONFORMED NAME: Berry Only Inc. DATE OF NAME CHANGE: 20100805 8-K 1 ktra-20231213.htm 8-K 8-K
0001498382false00014983822023-12-132023-12-13

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 13, 2023

 

KINTARA THERAPEUTICS, INC.

(Exact name of registrant as specified in its charter)

 

 

 

 

 

 

 

 

 

 

Nevada

 

001-37823

 

99-0360497

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

9920 Pacific Heights Blvd, Suite 150 San Diego, CA

92121

(Address of principal executive office)

(Zip Code)

Registrant’s telephone number, including area code: (858) 350-4364

N/A

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

 

 

 

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange

on which registered

Common Stock

 

KTRA

 

The Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On December 13, 2023, Kintara Therapeutics, Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company is not in compliance with the $1.00 Minimum Bid Price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market (the “Bid Price Requirement”). The Notice does not result in the immediate delisting of the Company’s common stock from The Nasdaq Capital Market.

 

The Nasdaq Listing Rules require listed securities to maintain a minimum bid price of $1.00 per share and, based upon the closing bid price of the Company’s common stock for the 30 consecutive business days preceding the receipt of the Notice, the Company no longer satisfies the Bid Price Requirement. The Notice indicated that the Company will be provided 180 calendar days in which to regain compliance, or until June 10, 2024. If at any time during this period the bid price of the Company’s common stock closes at or above $1.00 per share for a minimum of ten consecutive business days, the Nasdaq staff (the “Staff”) will provide the Company with a written confirmation of compliance and the matter will be closed.

 

Alternatively, if the Company fails to regain compliance with Rule 5550(a)(2) prior to the expiration of the initial 180 calendar day period, the Company may be eligible for an additional 180 calendar day compliance period, provided (i) it meets the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on The Nasdaq Capital Market (except for the Bid Price Requirement) and (ii) it provides written notice to Nasdaq of its intention to cure this deficiency during the second compliance period by effecting a reverse stock split, if necessary. In the event the Company does not regain compliance with Rule 5550(a)(2) prior to the expiration of the initial 180 calendar day period, and if it appears to the Staff that the Company will not be able to cure the deficiency, or if the Company is not otherwise eligible, the Staff will provide the Company with written notification that its securities are subject to delisting from The Nasdaq Capital Market. At that time, the Company may appeal the delisting determination to a Hearings Panel.

 

The Company intends to monitor the closing bid price of its common stock and is considering its options to regain compliance with the Bid Price Requirement. The Company’s receipt of the Notice does not affect the Company’s business, operations or reporting requirements with the Securities and Exchange Commission.

 

The Company is not currently in compliance with the continued listing requirements for The Nasdaq Capital Market. If the Company does not regain compliance and continue to meet the continued listing requirements, the Company’s common stock may be delisted from The Nasdaq Capital Market, which could affect the market price and liquidity for the Company’s common stock and reduce the Company’s ability to raise additional capital.

The Company’s common stock is listed on The Nasdaq Capital Market. In order to maintain that listing, the Company must satisfy minimum financial and other requirements including, without limitation, Nasdaq Listing Rule 5550(b)(1) which requires companies listed on The Nasdaq Capital Market to maintain stockholders’ equity of at least $2,500,000 (“the Stockholders’ Equity Requirement”) and the Bid Price Requirement. The Company is not currently in compliance with the Stockholders’ Equity Requirement or the Bid Price Requirement and intends to monitor its stockholders’ equity and minimum bid price of its common stock and may, if appropriate, consider implementing available options to regain compliance with the Stockholders’ Equity Requirement and/or the Bid Price Requirement. There can be no assurance that the Company will be able to regain compliance with the Stockholders’ Equity Requirement or the Bid Price Requirement or maintain compliance even if the Company implements an option that regains its compliance.

If the Company fails to regain compliance with the Stockholders’ Equity Requirement or the Bid Price Requirement or to meet the other applicable continued listing requirements for The Nasdaq Capital Market in the future, the Company’s common stock may be delisted and trade on the OTC Markets Group Inc. or other small trading

markets, which could reduce the liquidity of the Company’s common stock materially and result in a corresponding material reduction in the price of the Company’s common stock as well as reduce the Company’s ability to raise additional capital. In addition, if the Company’s common stock is delisted from Nasdaq and the trading price remains below $5.00 per share, trading in the Company’s common stock might also become subject to the requirements of certain rules promulgated under the Exchange Act, which require additional disclosure by broker-dealers in connection with any trade involving a stock defined as a “penny stock” (generally, any equity security not listed on a national securities exchange or quoted on Nasdaq that has a market price of less than $5.00 per share, subject to certain exceptions).

Safe Harbor for Forward-Looking Statements

Certain statements contained in this communication may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including statements containing the words “predicts,” “plans,” “expects,” “anticipates,” “believes,” “goal,” “target,” “estimate,” “potential,” “may,” “might,” “could,” “see,” “seek,” “forecast,” and similar words. Forward-looking statements are based on the Company’s current plans and expectations and involve risks and uncertainties which are, in many instances, beyond the Company’s control, and which could cause actual results to differ materially from those included in or contemplated or implied by the forward-looking statements. Such risks and uncertainties include, among others, the Company’s ability to regain compliance with the Stockholders’ Equity Requirement and Bid Price Requirement, and the other risks, uncertainties and factors detailed in the Company’s filings with the SEC, including in the Company’s Annual Report on Form 10-K for the year ended June 30, 2023, which was filed with the SEC on September 18, 2023. As a result of such risks, uncertainties and factors, the Company’s actual results may differ materially from any future results, performance or achievements discussed in or implied by the forward-looking statements contained herein. The Company is providing the information in this communication as of this date and assumes no obligations to update the information included in this communication or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

 

 

 

 

 

 

 

 

KINTARA THERAPEUTICS, INC.

 

 

 

Date: December 15, 2023

 

By:

 

/s/ Robert E. Hoffman

 

 

 

 

Name: Robert E. Hoffman

 

 

 

 

Title: Chief Executive Officer

 

 

 EX-101.SCH 2 ktra-20231213.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 100000 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.PRE 3 ktra-20231213_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EX-101.LAB 4 ktra-20231213_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Pre-commencement Issuer Tender Offer Entity Address, State or Province Trading Symbol Soliciting Material Entity Address, City or Town Written Communications Entity Central Index Key CIK Entity Tax Identification Number Entity Registrant Name Registrant Name Document Period End Date Period End Date Entity Address, Postal Zip Code Entity Incorporation, State or Country Code Local Phone Number City Area Code Pre-commencement Tender Offer Cover [Abstract] Cover Security Exchange Name Entity Emerging Growth Company Amendment Flag Amendment Entity File Number Entity Address, Address Line Two Entity Address, Address Line One Title of 12(b) Security Document Type Document Type XML 5 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover
Dec. 13, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Dec. 13, 2023
Entity File Number 001-37823
Entity Registrant Name KINTARA THERAPEUTICS, INC.
Entity Central Index Key 0001498382
Entity Tax Identification Number 99-0360497
Entity Incorporation, State or Country Code NV
Entity Address, Address Line One 9920 Pacific Heights Blvd
Entity Address, Address Line Two Suite 150
Entity Address, City or Town San Diego
Entity Address, State or Province CA
Entity Address, Postal Zip Code 92121
City Area Code 858
Local Phone Number 350-4364
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock
Trading Symbol KTRA
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 6 ktra-20231213_htm.xml IDEA: XBRL DOCUMENT 0001498382 2023-12-13 2023-12-13 0001498382 false 8-K 2023-12-13 KINTARA THERAPEUTICS, INC. NV 001-37823 99-0360497 9920 Pacific Heights Blvd Suite 150 San Diego CA 92121 858 350-4364 false false false false Common Stock KTRA NASDAQ false EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 1 23 1 false 0 0 false 0 false false R1.htm 100000 - Document - Cover Sheet http://www.kintara.com/20231213/taxonomy/role/DocumentCover Cover Cover 1 false false All Reports Book All Reports ktra-20231213.htm ktra-20231213.xsd ktra-20231213_lab.xml ktra-20231213_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ktra-20231213.htm": { "nsprefix": "ktra", "nsuri": "http://www.kintara.com/20231213", "dts": { "inline": { "local": [ "ktra-20231213.htm" ] }, "schema": { "local": [ "ktra-20231213.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "ktra-20231213_lab.xml" ] }, "presentationLink": { "local": [ "ktra-20231213_pre.xml" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 24, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://www.kintara.com/20231213/taxonomy/role/DocumentCover", "longName": "100000 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "C_c08dbf9d-36e0-4df7-97d8-b933334c6d21", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "ktra-20231213.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_c08dbf9d-36e0-4df7-97d8-b933334c6d21", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "ktra-20231213.htm", "first": true, "unique": true } } }, "tag": { "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.kintara.com/20231213/taxonomy/role/DocumentCover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.kintara.com/20231213/taxonomy/role/DocumentCover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.kintara.com/20231213/taxonomy/role/DocumentCover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "terseLabel": "Amendment", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.kintara.com/20231213/taxonomy/role/DocumentCover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.kintara.com/20231213/taxonomy/role/DocumentCover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "CIK", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.kintara.com/20231213/taxonomy/role/DocumentCover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.kintara.com/20231213/taxonomy/role/DocumentCover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.kintara.com/20231213/taxonomy/role/DocumentCover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.kintara.com/20231213/taxonomy/role/DocumentCover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.kintara.com/20231213/taxonomy/role/DocumentCover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.kintara.com/20231213/taxonomy/role/DocumentCover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.kintara.com/20231213/taxonomy/role/DocumentCover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.kintara.com/20231213/taxonomy/role/DocumentCover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.kintara.com/20231213/taxonomy/role/DocumentCover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.kintara.com/20231213/taxonomy/role/DocumentCover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.kintara.com/20231213/taxonomy/role/DocumentCover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.kintara.com/20231213/taxonomy/role/DocumentCover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.kintara.com/20231213/taxonomy/role/DocumentCover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "terseLabel": "Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.kintara.com/20231213/taxonomy/role/DocumentCover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.kintara.com/20231213/taxonomy/role/DocumentCover" ], "lang": { "en-us": { "role": { "label": "Document Type", "terseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.kintara.com/20231213/taxonomy/role/DocumentCover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.kintara.com/20231213/taxonomy/role/DocumentCover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "terseLabel": "Cover", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.kintara.com/20231213/taxonomy/role/DocumentCover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 13 0000950170-23-070743-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-23-070743-xbrl.zip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